Xilio Therapeutics, Inc.

XLO ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Oct 2, 2026 4
3 Oct 2, 2026 3
SCHEDULE 13G/A Aug 14, 2026
S-8 Aug 12, 2026 S-8
10-Q Aug 12, 2026 10-Q
8-K Aug 12, 2026 8-K
4 Jun 12, 2026 4
4 Jun 12, 2026 4
4 Jun 12, 2026 4
4 Jun 12, 2026 4
4 Jun 12, 2026 4
4 Jun 12, 2026 4
4 Jun 12, 2026 4
8-K Jun 12, 2026 8-K
EFFECT May 29, 2026
CORRESP May 27, 2026
S-3/A May 27, 2026 S-3/A
UPLOAD May 18, 2026
SCHEDULE 13G May 15, 2026
SCHEDULE 13G/A May 15, 2026
SCHEDULE 13G/A May 15, 2026
SCHEDULE 13G May 15, 2026
S-3 May 12, 2026 S-3
10-Q May 12, 2026 10-Q
8-K May 12, 2026 8-K
← Newer Page 1 of 15 · 357 filings Older →